GRANTS

427 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: The NIH anticipates providing $10 million per year to fund an estimated 15-20 awards.

Due Date: May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: The NIH anticipates providing $10 million per year to fund an estimated 15-20 awards.

Due Date: May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: New Concepts and Early Stage Research for Large-Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: NIH intends to fund an estimated 10-15 awards per fiscal year, corresponding to a total of $5 million over the two-year project period.

Due Date: May 1, 2019, October 29, 2019, May 1, 2020 October 29, 2020 , by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February, 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)

Sponsor: National Institute on Aging, National Cancer Institute

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Applicants should rarely exceed $1 million in total costs per year for a Phase I and $1.5 million in total costs per year for a Phase II/Phase IIB. Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the guidelines and early in the application planning process. In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the research project.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)

Sponsor: National Institute on Aging, National Cancer Institute

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.

Current Filters

No filters selected

Filter By